Terumo's Interventional Systems division is a global leader in cardiovascular care, providing low invasive devices for the treatment of coronary artery disease. Our philosophy is to deliver high quality devices with unique and innovative technology. We offer a comprehensive device portfolio including products for the diagnosis and treatment of coronary artery disease.
Meijers, T.A. et al. J Am Coll Cardiol Intv. 2021;(12):1293-303.
Featured product: Glidesheath Slender™ Introducer
20 patients, single arm, pharmocokinetics. Published.
Featured product: Ultimaster™ Sirolimus Eluting Coronary Stent System
60 MVD patients with OFDI, single arm, primary endpoint TLF @ 12M. Published
One of the largest, prospective worldwide registries
Featured products: Ultimaster™ Sirolimus Eluting Coronary Stent System, Ultimaster™ Tansei™ Sirolimus Eluting Coronary Stent System
This webpage can include promotional content regarding one or several products of Terumo Europe, or some procedures concerning the use or implantation of such products. This webpage is exclusively intended for healthcare professionals and is in no event directed to the general public
For Pharmaceutical Professionals interested in our B2B products portfolio, please visit Terumo Pharmaceutical Solutions.
This is HCP only content
website and cannot be refused. Other cookies are only placed if you choose to do so. For further information, please read our cookies policy.
Essential cookies to ensure the website functions well.
Cookies to help us measure the general use of our website.
Cookies that save personal information while browsing.